Detalles de la búsqueda
1.
The VEGFs/VEGFRs system in Alzheimer's and Parkinson's diseases: Pathophysiological roles and therapeutic implications.
Pharmacol Res
; 201: 107101, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38336311
2.
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors.
Pharmacol Res
; 192: 106782, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37127213
3.
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment.
Pharmacol Res
; 175: 105997, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34826600
4.
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib.
J Cell Mol Med
; 24(1): 465-475, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31758648
5.
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Pharmacol Res
; 159: 104957, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32485280
6.
Role of VEGFs/VEGFR-1 Signaling and its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models.
Int J Mol Sci
; 21(4)2020 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32085654
7.
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
Int J Mol Sci
; 21(21)2020 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33153019
8.
Multiple Sclerosis Treatment and Melanoma Development.
Int J Mol Sci
; 21(8)2020 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32331328
9.
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.
J Pharmacol Exp Ther
; 364(1): 77-86, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29025978
10.
Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors.
Pharmacol Res
; 136: 97-107, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30170190
11.
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research.
J Cancer
; 15(1): 1-19, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164270
12.
Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion.
J Pharmacol Exp Ther
; 347(1): 164-72, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23892569
13.
Targeting immunoproteasome in neurodegeneration: A glance to the future.
Pharmacol Ther
; 241: 108329, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526014
14.
Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.
Pharmacol Ther
; 236: 108106, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990642
15.
Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
FEBS J
; 289(1): 183-198, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252269
16.
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor.
Cancers (Basel)
; 14(22)2022 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428669
17.
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.
Cancers (Basel)
; 14(15)2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35954369
18.
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose.
Cell Biosci
; 12(1): 108, 2022 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35842713
19.
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.
J Exp Clin Cancer Res
; 40(1): 320, 2021 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649573
20.
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.
Biochem Pharmacol
; 180: 114169, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710969